Protagenic Therapeutics receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period

Protagenic Therapeutics, Inc.new

Nasdaq notified PTIX on July 24, 2024 of non-compliance with minimum $1.00 bid price for 30 consecutive business days.
Company has until January 20, 2025 to regain compliance; requires closing bid of $1.00 for at least 10 consecutive days.
If not compliant by Jan 20, 2025, PTIX may qualify for an additional 180-day cure period if it meets other listing standards.
Failure to cure could lead to delisting; the company may appeal any delisting determination to a Nasdaq hearings panel.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.